147 related articles for article (PubMed ID: 37770592)
1. Circulating biomarkers of extracellular matrix dysregulation are associated with adverse post-stage 2 outcomes in infants with single ventricle heart disease.
Frank BS; Nandy D; Khailova L; Mitchell MB; Morgan GJ; Twite M; DiMaria MV; Davidson JA
Sci Rep; 2023 Sep; 13(1):16318. PubMed ID: 37770592
[TBL] [Abstract][Full Text] [Related]
2. Proteomic profiling identifies key differences between inter-stage infants with single ventricle heart disease and healthy controls.
Frank BS; Khailova L; Silveira L; Mitchell MB; Morgan GJ; Hsieh EWY; DiMaria MV; Twite M; Klawitter J; Davidson JA
Transl Res; 2021 Mar; 229():24-37. PubMed ID: 33045409
[TBL] [Abstract][Full Text] [Related]
3. Arginine-NO metabolites are associated with morbidity in single ventricle infants undergoing stage 2 palliation.
Frank BS; Niemiec S; Khailova L; Mancuso CA; Lehmann T; Mitchell MB; Morgan GJ; Twite M; DiMaria MV; Klawitter J; Davidson JA
Pediatr Res; 2024 Apr; ():. PubMed ID: 38565916
[TBL] [Abstract][Full Text] [Related]
4. Interstage Single Ventricle Heart Disease Infants Show Dysregulation in Multiple Metabolic Pathways: Targeted Metabolomics Analysis.
Frank BS; Khailova L; Dekermanjian J; Mitchell MB; Morgan GJ; Twite M; Christians U; DiMaria MV; Klawitter J; Davidson JA
JACC Adv; 2023 Jan; 2(1):. PubMed ID: 36875009
[TBL] [Abstract][Full Text] [Related]
5. Increased Circulating Endothelin 1 Is Associated With Postoperative Hypoxemia in Infants With Single-Ventricle Heart Disease Undergoing Superior Cavopulmonary Anastomosis.
Frank BS; Khailova L; Silveira L; Mitchell MB; Morgan GJ; DiMaria MV; Davidson JA
J Am Heart Assoc; 2022 Mar; 11(6):e024007. PubMed ID: 35243904
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase imbalance in inguinal hernia formation.
Antoniou GA; Tentes IK; Antoniou SA; Simopoulos C; Lazarides MK
J Invest Surg; 2011; 24(4):145-50. PubMed ID: 21675849
[TBL] [Abstract][Full Text] [Related]
7. Control of extracellular matrix homeostasis of normal cartilage by a TGFbeta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro.
Wang L; Almqvist KF; Veys EM; Verbruggen G
Osteoarthritis Cartilage; 2002 Mar; 10(3):188-98. PubMed ID: 11869079
[TBL] [Abstract][Full Text] [Related]
8. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
[TBL] [Abstract][Full Text] [Related]
9. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
[TBL] [Abstract][Full Text] [Related]
10. Imbalance between matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) contributes to bladder compliance changes in rabbits with partial bladder outlet obstruction (PBOO).
Yang L; Liu R; Wang X; He D
BJU Int; 2013 Aug; 112(4):E391-7. PubMed ID: 23305285
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of inductive effects of different concentrations of cyclosporine A on MMP-1, MMP-2, MMP-3, TIMP-1, and TIMP-2 in fetal and adult human gingival fibroblasts.
Nazemisalman B; Sajedinejad N; Darvish S; Vahabi S; Gudarzi H
J Basic Clin Physiol Pharmacol; 2019 Mar; 30(3):. PubMed ID: 30913036
[TBL] [Abstract][Full Text] [Related]
12. Effect of simvastatin on MMPs and TIMPs in cigarette smoke-induced rat COPD model.
Sun J; Bao J; Shi Y; Zhang B; Yuan L; Li J; Zhang L; Sun M; Zhang L; Sun W
Int J Chron Obstruct Pulmon Dis; 2017; 12():717-724. PubMed ID: 28260878
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Tayebjee MH; Nadar S; Blann AD; Gareth Beevers D; MacFadyen RJ; Lip GY
Am J Hypertens; 2004 Sep; 17(9):764-9. PubMed ID: 15363817
[TBL] [Abstract][Full Text] [Related]
14. Profile of Metalloproteinases and Their Association with Inflammatory Markers in Pleural Effusions.
Teixeira LR; Dias MB; Sales RK; Antonangelo L; Alvarenga VA; Puka J; Marchi E; Acencio MM
Lung; 2016 Dec; 194(6):1021-1027. PubMed ID: 27677622
[TBL] [Abstract][Full Text] [Related]
15. Tissue Inhibitor of Metalloproteinase-1 Promotes Polymorphonuclear Neutrophil (PMN) Pericellular Proteolysis by Anchoring Matrix Metalloproteinase-8 and -9 to PMN Surfaces.
Wang X; Rojas-Quintero J; Wilder J; Tesfaigzi Y; Zhang D; Owen CA
J Immunol; 2019 Jun; 202(11):3267-3281. PubMed ID: 31019060
[TBL] [Abstract][Full Text] [Related]
16. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
17. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.
Tayebjee MH; Lip GY; Blann AD; Macfadyen RJ
Thromb Res; 2005; 115(3):205-10. PubMed ID: 15617743
[TBL] [Abstract][Full Text] [Related]
18. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension.
Lepetit H; Eddahibi S; Fadel E; Frisdal E; Munaut C; Noel A; Humbert M; Adnot S; D'Ortho MP; Lafuma C
Eur Respir J; 2005 May; 25(5):834-42. PubMed ID: 15863640
[TBL] [Abstract][Full Text] [Related]
19. Expression of Matrix Metalloproteinases in the Circulating Immune Cells in Children with
Helmin-Basa A; Kubiszewska I; Wiese-Szadkowska M; Strzyżewska E; Skalska-Bugała A; Balcerowska S; Rasmus M; Balcerczyk D; Pokrywczyńska M; Michałkiewicz J; Krogulska A; Główczewski A; Szaflarska-Popławska A
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958643
[No Abstract] [Full Text] [Related]
20. Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study.
Hansson J; Vasan RS; Ärnlöv J; Ingelsson E; Lind L; Larsson A; Michaëlsson K; Sundström J
PLoS One; 2011 Jan; 6(1):e16185. PubMed ID: 21283828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
